|
ARL15 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.856300E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.930400E-02 |
| Normal-vs-Stage2 |
1.106180E-01 |
| Normal-vs-Stage3 |
4.566600E-01 |
| Normal-vs-Stage4 |
8.945800E-01 |
| Stage1-vs-Stage2 |
7.596000E-01 |
| Stage1-vs-Stage3 |
2.567600E-01 |
| Stage1-vs-Stage4 |
1.758390E-01 |
| Stage2-vs-Stage3 |
3.011600E-01 |
| Stage2-vs-Stage4 |
2.087000E-01 |
| Stage3-vs-Stage4 |
6.493400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.992300E-02 |
| Normal-vs-AfricanAmerican |
1.833580E-01 |
| Normal-vs-Asian |
2.805600E-01 |
| Caucasian-vs-AfricanAmerican |
4.981000E-01 |
| Caucasian-vs-Asian |
8.995200E-01 |
| AfricanAmerican-vs-Asian |
6.563200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.699700E-02 |
| Normal-vs-Female |
1.663590E-01 |
| Male-vs-Female |
1.625410E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.587510E-02 |
| Normal-vs-Age(41-60Yrs) |
5.123800E-01 |
| Normal-vs-Age(61-80Yrs) |
2.146200E-01 |
| Normal-vs-Age(81-100Yrs) |
5.388800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.549800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.544200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.862600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.090200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.913200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.594000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.135500E-02 |
| Classical-VS-Follicular |
1.478630E-01 |
| Classical-VS-Other |
2.099800E-01 |
| Classical-VS-Normal |
1.085800E-02 |
| Tall-VS-Follicular |
3.411800E-01 |
| Tall-VS-Other |
7.317400E-01 |
| Tall-VS-Normal |
7.386200E-01 |
| Follicular-VS-Other |
4.753200E-01 |
| Follicular-VS-Normal |
4.398800E-01 |
| Other-VS-Normal |
5.547000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.081600E-01 |
| Normal-vs-N1 |
1.918550E-01 |
| N0-vs-N1 |
3.344400E-01 |
|
|
